Dermatology Excimer Laser Market Size, Share, Growth, and Industry Analysis, By Type (Table Top Excimer Laser,Hand Held Excimer Laser,Trolley Mounted Excimer Laser), By Application (Hospital,Dermatology Clinic,Skin Care Center,Others), Regional Insights and Forecast to 2035

Dermatology Excimer Laser Market Overview

The global Dermatology Excimer Laser Market size is projected to grow from USD 850.66 million in 2026 to USD 933.34 million in 2027, reaching USD 1960.04 million by 2035, expanding at a CAGR of 9.72% during the forecast period.

The Dermatology Excimer Laser Market is increasingly used to treat localized skin disorders such as psoriasis, vitiligo, and atopic dermatitis. In 2023, the global dermatology excimer laser market was estimated at about USD 584.5 million, with trolley-mounted excimer lasers holding about 43.6 % share of device installations that year. In clinical settings, handheld excimer lasers accounted for approximately 18 % of new units launched in 2023, while tabletop systems made up about 38.4 %. 

In the USA market, the dermatology excimer laser market is relatively mature, with U.S. installations numbering over 1,200 units by 2024 across hospitals, dermatology clinics, and cosmetic centers. The U.S. adoption share is roughly 38 % of global units, with dermatology clinics in the U.S. receiving 770 new units in a three-year span. In 2023 the U.S. market accounted for USD 228.7 million of installed base valuation. The U.S. treats more than 7.5 million diagnosed psoriasis patients, boosting excimer laser demand in major dermatology hubs like California, Texas, and Florida. 

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 42 % of dermatologists cite “increased prevalence of psoriasis and vitiligo” as primary drivers.
• Major Market Restraint: 29 % of potential buyers cite “high cost of device acquisition and maintenance” as barriers.
• Emerging Trends: 31 % of new excimer laser launches in 2023–2024 feature AI or integrated imaging modules.
• Regional Leadership: North America accounted for 38 % share of installed units globally in 2023.
• Competitive Landscape: Top five companies command about 47 % share of global excimer laser units.
• Market Segmentation: Trolley-mounted systems held 43.6 % share in 2023 of device segment.
• Recent Development: In 2024, 22 % of excimer laser units delivered globally included new software upgrades enabling remote monitoring.

Dermatology Excimer Laser Market Latest Trends

In 2023–2024, the Dermatology Excimer Laser Market saw strong adoption of AI-assisted lesion mapping modules: about 31 % of new system orders integrated AI imaging. Trolley-mounted excimer lasers continued dominating with 43.6 % share of installed base in 2023, while handheld units gained traction—comprising roughly 18 % of new system launches. Meanwhile, tabletop systems accounted for 38.4 % of new installations. In the U.S., dermatology practices placed 770 new units over three years, making up roughly 65 % of new global placements. Clinics expanded usage to treat over 1.2 million vitiligo patches per year across the U.S. Integration of digital connectivity and remote monitoring options appeared in 22 % of devices shipped in 2024. 

Dermatology Excimer Laser Market Dynamics

Global Dermatology Excimer Laser Market, valued at USD 775.3 million, demonstrates strong dynamic momentum supported by technological progress, increasing dermatological disease prevalence, and expanding clinical adoption. Around 7.5 million patients worldwide undergo excimer laser treatments annually, highlighting a steady increase in device utilization. The demand is driven by the 42% rise in psoriasis and vitiligo diagnosis rates in the last five years, directly influencing new equipment installations across hospitals and dermatology clinics.

DRIVER

" Rising incidence of chronic skin disorders"

The primary growth driver in the dermatology excimer laser market is the increasing incidence and prevalence of chronic dermatological conditions. For example, an estimated 223 million people worldwide suffer from atopic dermatitis as of 2022; psoriasis affects about 7.5 million diagnosed patients in the U.S. alone. In 2023 excimer lasers treated over 2.4 million psoriasis lesions globally across installed systems. Rising urbanization and pollution have contributed to 12 % year-on-year increase in dermatitis cases in Asia. Dermatologists cite that 42 % of new excimer laser purchases are directly attributable to expanded patient base for vitiligo, psoriasis, and atopic dermatitis. 

RESTRAINT

"High cost of acquisition and maintenance"

A significant restraint for market expansion is the capital intensity of excimer laser systems. Approximately 29 % of potential buyers indicate upfront device cost as a major barrier. Device installations often require investments in cooling systems, quality control, and calibration modules, adding 15–20 % to base system cost. Annual service contracts and consumables (gas, optics, filters) can consume 8–12 % of purchase value annually. In mid-sized clinics, hesitance is seen: 24 % report that ROI over 5 years is uncertain. 

OPPORTUNITY

"Hybrid device integration and modular platforms"

One major opportunity lies in development of hybrid systems combining excimer lasers with other modalities (e.g., fractional lasers, LED, photodynamic therapy). In 2024, 19 % of new devices shipped were hybrid or modulatable units. Modular upgradable platforms allow clinics to order a base trolley excimer unit and later add handheld modules; this approach captured 13 % of new orders in 2024. Cloud-enabled monitoring, remote diagnostics, and firmware updates were built into 22 % of excimer systems shipped in 2024. In underserved regions, mobile excimer units mounted in vans have begun deployment in 8 pilot programs, covering rural populations in India, China, and Latin America. 

CHALLENGE

" Clinical training, standardization, and usage variations"

A critical challenge lies in the clinical training and operational standardization required for excimer laser usage. Approximately 21 % of clinics report that staff require 3–6 months of hands-on training before independent operation. Variation in energy dosing protocols across physicians is observed: 18 % of repigmentation failures stem from inconsistent clinician technique. Many regions lack standard treatment guidelines: in Southeast Asia, 14 countries still rely primarily on older broadband UVB and rarely invest in training excimer protocols. 

Dermatology Excimer Laser Market saw. Segmentation

The Segmentation Analysis of the dermatology excimer laser market distinguishes by Type and Application. The market is divided into types (Table Top, Hand Held, Trolley Mounted). In 2023, trolley mounted devices held 43.6 % share, tabletop 38.4 %, handheld 18.0 % of global installations. Applications include hospitals, dermatology clinics, skin care centers, and others—dermatology clinics capture over 65 % of deployment share, hospitals around 25 %, and skin care centers 10 %.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Table Top Excimer Laser: Tabletop excimer lasers are compact, benchtop systems suited for dermatology clinics with limited floor space. In 2023, tabletop systems made up 38.4 % of global installations. Many mid-tier dermatology clinics deploy these models because they require minimal footprint and can serve moderate-throughput patient loads. In the U.S., 260 new tabletop units were delivered during 2022–2023, representing 34 % of new devices.

The Table Top Excimer Laser segment is valued at USD 275.6 million in 2025, accounting for 35.5% market share, and is expected to reach USD 612.8 million by 2034, expanding at a CAGR of 9.65% due to compact design and portability.

Top 5 Major Dominant Countries in the Table Top Excimer Laser Segment

• United States: Market size USD 86.2 million (2025), share 31.3%, CAGR 9.8%; widespread clinical adoption in dermatology practices drives strong device penetration.
• Germany: Market size USD 48.5 million (2025), share 17.6%, CAGR 9.5%; technological integration in compact table units enhances treatment precision and usage.
• China: Market size USD 44.1 million (2025), share 16.0%, CAGR 9.9%; expanding dermatology infrastructure and increased affordability foster market growth.
• Japan: Market size USD 36.9 million (2025), share 13.4%, CAGR 9.6%; consistent innovation in energy-efficient tabletop excimer systems strengthens market position.
• India: Market size USD 28.7 million (2025), share 10.4%, CAGR 10.1%; growing demand from dermatology clinics and urban healthcare centers boosts expansion.

Hand Held Excimer Laser: Handheld excimer lasers are portable, flexible units ideal for targeted spot treatment and home care settings. In 2023, handheld systems accounted for 18 % of new placements globally. In Asia, handheld adoption grew by 28 % year-on-year in 2023, especially in small clinics that lack space for trolley systems. Handheld units deliver lower power output but are ideal for small vitiligo patches or precision psoriasis therapy.

The Hand Held Excimer Laser segment holds a market value of USD 162.8 million in 2025, representing 21.0% of total share, and is forecasted to reach USD 366.5 million by 2034, advancing at a CAGR of 9.84% supported by its portability and lower maintenance requirements.

Top 5 Major Dominant Countries in the Hand Held Excimer Laser Segment

• United States: Market size USD 49.5 million (2025), share 30.4%, CAGR 9.9%; leading installations across clinics favoring compact, high-precision handheld systems.
• China: Market size USD 36.3 million (2025), share 22.3%, CAGR 10.0%; growing preference for mobile phototherapy and cost-effective handheld devices.
• South Korea: Market size USD 24.8 million (2025), share 15.2%, CAGR 9.7%; adoption in aesthetic and dermatology centers accelerates due to compact design.
• Japan: Market size USD 23.1 million (2025), share 14.2%, CAGR 9.6%; increasing deployment in hospitals for outpatient dermatological treatments.
• Germany: Market size USD 18.6 million (2025), share 11.4%, CAGR 9.5%; expanded use in psoriasis and vitiligo treatments through personalized therapy modules

Trolley Mounted Excimer Laser: Trolley mounted excimer lasers are full-scale systems with mobility on wheels, high power output, and multi-module support. In 2023 they commanded 43.6 % share of device installations globally. In major hospitals and large dermatology centers, trolley systems dominate because they support high throughput and larger lesion areas. In the U.S., 410 trolley units were installed over 2022–2023 across leading dermatology centers. 

The Trolley Mounted Excimer Laser segment leads the market with USD 336.9 million in 2025, contributing 43.5% market share, projected to reach USD 807.1 million by 2034, growing at a CAGR of 9.72%, owing to advanced features and high-volume hospital usage.

Top 5 Major Dominant Countries in the Trolley Mounted Excimer Laser Segment

• United States: Market size USD 115.4 million (2025), share 34.3%, CAGR 9.8%; strong integration in hospitals and dermatology clinics drives consistent demand.
• China: Market size USD 78.1 million (2025), share 23.2%, CAGR 9.9%; robust healthcare infrastructure and high patient pool support steady expansion.
• Germany: Market size USD 55.7 million (2025), share 16.5%, CAGR 9.5%; demand led by multi-functional laser systems with digital interfaces.
• Japan: Market size USD 48.9 million (2025), share 14.5%, CAGR 9.6%; focus on AI-enabled laser technology enhances adoption across advanced care centers.
• India: Market size USD 38.8 million (2025), share 11.5%, CAGR 10.0%; rising psoriasis and vitiligo cases fuel rapid demand growth.

BY APPLICATION

Hospital: Hospitals represent approximately 25 % of dermatology excimer laser deployments. In 2023, hospitals installed over 180 new excimer units globally. Hospitals use excimer lasers in dermatology and immunology wards, for combined care in in-patient settings. In the U.S., hospital health systems accounted for 26 % of excimer installations; 90 hospital systems deployed at least one excimer unit by 2024. Hospital units often require integration with electronic medical record systems; 78 % of hospital installations include digital patient data linking. 

The Hospital application segment is valued at USD 193.7 million in 2025, representing 25.0% market share, and is expected to expand at a CAGR of 9.6%, driven by adoption in advanced dermatology departments and multi-specialty hospitals.

Top 5 Major Dominant Countries in the Hospital Application

• United States: Market size USD 61.2 million (2025), share 31.6%, CAGR 9.8%; advanced infrastructure and frequent device upgrades sustain strong installation rates.
• Germany: Market size USD 35.5 million (2025), share 18.3%, CAGR 9.5%; large dermatology hospital networks boost excimer device utilization.
• China: Market size USD 33.4 million (2025), share 17.2%, CAGR 9.9%; widespread government healthcare expansion increases procurement of excimer systems.
• Japan: Market size USD 30.6 million (2025), share 15.8%, CAGR 9.7%; focus on precision phototherapy and hospital-based research enhances adoption.
• India: Market size USD 25.8 million (2025), share 13.3%, CAGR 10.0%; increased hospital integration of laser therapy units drives market expansion.

Dermatology Clinic: Dermatology clinics are the dominant application, accounting for over 65 % of excimer laser deployments. In 2023, over 380 new units globally were placed in specialist dermatology clinics. Clinics choose excimer lasers to treat localized skin conditions with minimal downtime and high patient throughput. In the U.S., dermatology clinics have installed more than 770 new devices over three years, forming the backbone of market growth. Clinics often prefer tabletop and handheld types due to space constraints; 58 % of clinic units are tabletop or handheld.

The Dermatology Clinic segment dominates the market with USD 426.1 million in 2025, capturing 55.0% share, and is forecasted to grow at a CAGR of 9.8%, fueled by high outpatient treatment volumes and personalized therapy programs.

Top 5 Major Dominant Countries in the Dermatology Clinic Application

• United States: Market size USD 138.4 million (2025), share 32.5%, CAGR 9.9%; large clinic networks and repeat patient base enhance device turnover.
• China: Market size USD 87.3 million (2025), share 20.5%, CAGR 10.0%; expanding urban clinic infrastructure boosts adoption rates.
• Germany: Market size USD 63.9 million (2025), share 15.0%, CAGR 9.6%; high dermatologist density supports stable market demand.
• Japan: Market size USD 56.8 million (2025), share 13.3%, CAGR 9.7%; premium clinic models and aesthetic integration stimulate device procurement.
• India: Market size USD 47.6 million (2025), share 11.2%, CAGR 10.1%; growing private dermatology sector drives high-volume installations.

Skin Care Center: Skin care centers constitute about 10 % of excimer laser device installations. In 2023, ~60 new units were installed in aesthetic and skincare centers globally. These centers often supplement cosmetic services, offering targeted treatments for pigmentation, scars, or vitiligo patches. Many centers choose handheld or compact tabletop excimer lasers: 68 % of new skin care center units are handheld or tabletop. Treatment sessions in skin care centers often average 4 minutes per patch. 

The Skin Care Center segment holds a market value of USD 108.5 million in 2025, with 14.0% market share, and will grow at a CAGR of 9.7%, supported by the rising demand for aesthetic and non-invasive skin treatments.

Top 5 Major Dominant Countries in the Skin Care Center Application

• United States: Market size USD 35.9 million (2025), share 33.1%, CAGR 9.8%; growing cosmetic industry and high disposable income boost excimer adoption.
• China: Market size USD 27.3 million (2025), share 25.1%, CAGR 9.9%; rapid expansion of beauty and dermatology hybrid clinics enhances growth.
• Japan: Market size USD 17.4 million (2025), share 16.0%, CAGR 9.6%; technological innovation in compact laser systems increases efficiency.
• Germany: Market size USD 15.1 million (2025), share 13.9%, CAGR 9.5%; personalized aesthetic treatments expand use of laser-based phototherapy.
• India: Market size USD 12.8 million (2025), share 11.8%, CAGR 10.0%; growth of premium skin care chains strengthens market penetration.

Others: “Others” include specialty clinics, research centers, mobile units, and telemedicine setups. They account for approximately 5 % of installations. In 2023, about 30 units went into research and pilot mobile programs. Some mobile van units deployed in rural India and Africa carried trolley-mounted excimer systems adapted for power variability; those represent 8 pilot projects. Research centers make use of flexible handheld prototypes—about 11 units in 2023 were placed in university dermatology research labs. 

The Others segment (including research centers, mobile units, and specialty clinics) is valued at USD 47.0 million in 2025, with 6.0% share, expanding at a CAGR of 9.5%, driven by emerging applications in medical research and tele-dermatology.

Top 5 Major Dominant Countries in the Others Application

• United States: Market size USD 15.4 million (2025), share 32.7%, CAGR 9.6%; growing investments in dermatological R&D and portable treatment solutions.
• Germany: Market size USD 9.7 million (2025), share 20.6%, CAGR 9.4%; adoption in academic hospitals and university research centers.
• China: Market size USD 8.5 million (2025), share 18.1%, CAGR 9.8%; state-backed medical research supports continuous market innovation.
• Japan: Market size USD 7.6 million (2025), share 16.2%, CAGR 9.5%; expansion in experimental dermatology and AI-based treatment studies.
• India: Market size USD 5.8 million (2025), share 12.4%, CAGR 9.9%; pilot testing of mobile excimer therapy units enhances accessibility.

Regional Outlook for the Dermatology Excimer Laser Market 

The regional outlook for the dermatology excimer laser market shows that North America leads in installed base share (≈ 38 %), followed by Europe (~28 %), Asia-Pacific (~25 %), and Middle East & Africa (~9 %), with recent installations growing fastest in Asia. In recent years, North America has installed over 220 new units annually, Europe about 150 units, Asia-Pacific ~130 units, and MEA ~40 units. Regional expansions are driven by rising dermatological disease incidence, improved healthcare infrastructure, and increasing adoption of minimally invasive devices.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds approximately 38 % of global excimer laser installations as of 2023, reinforcing its leadership position in the dermatology excimer laser market. In the U.S. alone, more than 1,200 excimer laser units were installed across hospitals and clinics by 2024, representing about 33 % of the global device count. Dermatology clinics in the U.S. acquired 770 new systems over the 2021–2024 period, accounting for nearly 65 % of U.S. device placements. Hospitals and larger health systems make up the remaining portion, with hospital systems installing over 180 units in a multi-year period. 

The North America Dermatology Excimer Laser Market is valued at USD 312.4 million in 2025, representing 40.3% of global share, and is projected to expand at a CAGR of 9.8%, driven by technological leadership and widespread clinical acceptance.

North America – Major Dominant Countries in the Dermatology Excimer Laser Market

• United States: Market size USD 245.7 million (2025), share 78.6%, CAGR 9.9%; extensive adoption across hospitals and clinics makes it the global leader.
• Canada: Market size USD 27.6 million (2025), share 8.8%, CAGR 9.5%; rising public healthcare investment increases device installations.
• Mexico: Market size USD 18.3 million (2025), share 5.9%, CAGR 9.6%; expanding private dermatology sector contributes to higher usage.
• Brazil: Market size USD 13.2 million (2025), share 4.2%, CAGR 9.4%; introduction of new laser-based therapies enhances demand.
• Cuba: Market size USD 7.6 million (2025), share 2.5%, CAGR 9.3%; gradual modernization of healthcare drives small-scale adoption.

EUROPE

In Europe, the dermatology excimer laser market accounts for about 28 % of global installations in 2023, placing it second in regional share. European dermatology and hospital centers house over 700 excimer units across key countries including Germany, France, the UK, Italy, and Spain. Trolley-mounted systems dominate with 42 % share, tabletop represent 38 %, and handheld around 20 %. The UK, Germany, and France together command over 55 % of European device installations. German dermatology centers installed 90 new units in 2022–2023 alone, representing 18 % of European new placements. France installed 70 units, the U.K. 65, Italy 55, and Spain 50 over that same period. 

The Europe Dermatology Excimer Laser Market stands at USD 214.1 million in 2025, accounting for 27.6% global share, and is projected to grow at a CAGR of 9.6%, supported by strong healthcare infrastructure and technological advancement.

Europe – Major Dominant Countries in the Dermatology Excimer Laser Market

• Germany: Market size USD 68.5 million (2025), share 32.0%, CAGR 9.5%; largest European base for excimer technology adoption in clinical dermatology.
• France: Market size USD 44.2 million (2025), share 20.6%, CAGR 9.4%; robust adoption in public hospitals and specialty clinics.
• United Kingdom: Market size USD 39.7 million (2025), share 18.5%, CAGR 9.6%; growing demand for outpatient dermatology procedures.
• Italy: Market size USD 34.8 million (2025), share 16.3%, CAGR 9.7%; rapid adoption in aesthetic laser therapy centers.
• Spain: Market size USD 26.9 million (2025), share 12.6%, CAGR 9.5%; expanding dermatology infrastructure increases excimer accessibility.

ASIA-PACIFIC

Asia-Pacific holds approximately 25 % share of global excimer laser installations as of 2023, with rapidly rising adoption. Countries such as China, India, Japan, South Korea, and Australia lead in new deployments. In 2023, Asia installed about 130 new systems, representing 28 % year-on-year growth. China contributed around 55 units, India 30, Japan 20, South Korea 15, and Australia 10. Trolley-mounted systems account for 40 % share in Asia, tabletop ~35 %, handheld ~25 %. India’s excimer adoption is growing from about 45 units in 2021 to over 120 units by 2024, contributing 15 % of Asia’s installed base. Chinese dermatology networks installed 180 units by 2024, covering over 35 cities. Southeast Asia (Indonesia, Malaysia, Thailand, Vietnam) added 25 units in 2023.

The Asia Dermatology Excimer Laser Market is valued at USD 193.8 million in 2025, capturing 25.0% global share, and is forecasted to expand at a CAGR of 9.9%, propelled by population growth, urbanization, and skin disorder prevalence.

Asia – Major Dominant Countries in the Dermatology Excimer Laser Market

• China: Market size USD 81.4 million (2025), share 42.0%, CAGR 10.0%; rapid expansion of urban clinics and hospital dermatology departments.
• India: Market size USD 52.2 million (2025), share 26.9%, CAGR 10.1%; growing awareness of phototherapy drives market acceleration.
• Japan: Market size USD 37.8 million (2025), share 19.5%, CAGR 9.8%; advanced R&D investment strengthens local manufacturing capacity.
• South Korea: Market size USD 15.4 million (2025), share 8.0%, CAGR 9.7%; innovation in aesthetic dermatology boosts excimer device sales.
• Australia: Market size USD 7.0 million (2025), share 3.6%, CAGR 9.6%; rising cosmetic dermatology demand enhances technology adoption.

MIDDLE EAST & AFRICA

Middle East & Africa (MEA) constitute about 9 % share of global excimer laser installations in 2023. The region has around 180 units spread across major hubs in Saudi Arabia, UAE, South Africa, Egypt, and Nigeria. Trolley-mounted units form 38 % of installations, tabletop 40 %, handheld 22 %. Saudi Arabia installed approximately 40 units by 2024, UAE 30 units, South Africa 35 units, Egypt 50 units, and Nigeria 25 units. Many installations are in private dermatology clinics and cosmetic centers; hospital-based deployment is limited. Clinics in UAE and Saudi Arabia treat over 210,000 vitiligo or pigmentation cases annually using excimer lasers. In South Africa, adoption is moderate: 25 new units added in 2023. 

The Middle East and Africa Dermatology Excimer Laser Market holds a value of USD 54.9 million in 2025, representing 7.1% global share, and is projected to expand at a CAGR of 9.5%, supported by growing healthcare investments and clinic expansions.

Middle East and Africa – Major Dominant Countries in the Dermatology Excimer Laser Market

• Saudi Arabia: Market size USD 16.7 million (2025), share 30.4%, CAGR 9.6%; hospital infrastructure modernization increases excimer demand.
• United Arab Emirates: Market size USD 11.4 million (2025), share 20.8%, CAGR 9.5%; rise in aesthetic centers strengthens adoption.
• South Africa: Market size USD 9.8 million (2025), share 17.8%, CAGR 9.4%; expanding private dermatology services support steady growth.
• Egypt: Market size USD 9.0 million (2025), share 16.4%, CAGR 9.6%; introduction of advanced phototherapy technologies boosts usage.
• Nigeria: Market size USD 8.0 million (2025), share 14.6%, CAGR 9.3%; increased public sector investment drives accessibility in regional hospitals.

List of Top Dermatology Excimer Laser Companies

• Fosun International Holdings
• Ra Medical Systems
• Fotona
• Lumenis
• Shenzhen GSD Tech
• Sincoheren
• HologicFosun International Holdings
• Ra Medical Systems
• Fotona
• Lumenis
• Shenzhen GSD Tech
• Sincoheren
• Hologic

Top Two Companies with Highest Market Shares

• Fosun International Holdings: holds approx. 12 % share of global excimer laser device units, especially in China and Asia markets.
• Lumenis: commands roughly 11 % share of global excimer laser installations across North America, Europe, and Asia.

Investment Analysis and Opportunities

Investment in the dermatology excimer laser market is expanding as both device manufacturers and dermatology service providers commit capital. In 2023–2024, disclosed investments exceeded USD 120 million in new laser R&D and clinic expansions. Over 45 new dermatology clinics globally announced laser adoption, committing to at least one excimer system each. Many investment funds are targeting modular excimer platforms—in 2024 about 19 % of R&D budgets in leading firms went to hybrid or upgradeable designs. Strategic partnerships are on the rise: 14 joint ventures between laser OEMs and clinic chains emerged between 2022–2024, aiming to secure bulk device orders. In emerging markets, governments are funding subsidized skin health initiatives: India allocated funding for 50 excimer-equipped dermatology units in rural zones by 2025. A

New Product Developments

In the last two years, the dermatology excimer laser industry has introduced several innovations. In 2023, a major OEM released a hybrid excimer-fractional device combining 308 nm UVB and fractional ablative laser in one trolley system, representing 19 % of new premium orders. In 2024, an upgraded handheld module was launched supporting variable beam shaping; that module accounted for 13 % of new handheld sales. Another OEM introduced AI lesion mapping software integrated in 22 % of excimer units shipped in 2024, enabling automated patch identification. In Europe, a compact bench-top excimer with remote telemetry capabilities was released in 2023, and ~75 units were shipped in pilot launch countries. 

Five Recent Developments

• In 2024, approximately 22% of excimer laser units delivered globally included remote monitoring and cloud-based diagnostic capabilities, improving device management and maintenance efficiency.
• During 2023–2024, nearly 31% of newly launched excimer laser systems incorporated AI-assisted lesion mapping and integrated imaging technologies for improved treatment accuracy.
• In 2023, a major manufacturer introduced a hybrid excimer-fractional laser platform combining 308 nm UVB therapy and fractional laser technology, accounting for approximately 19% of new premium device orders.
• In 2024, an upgraded handheld excimer laser module with variable beam-shaping technology was launched and represented about 13% of new handheld system sales worldwide.
• During 2023, a compact bench-top excimer laser with remote telemetry capabilities was introduced in Europe, with approximately 75 units shipped during its pilot launch phase.

Report Coverage of Dermatology Excimer Laser Market

This Dermatology Excimer Laser Market Report provides comprehensive coverage of device deployment, competitive landscape, and growth levers over the forecast period. It includes analysis of Dermatology Excimer Laser Market Size in terms of unit installations, segment-wise device shares, and growth in adoption rates across regions. The report includes Dermatology Excimer Laser Market Analysis by type (tabletop, handheld, trolley) and by application (hospitals, dermatology clinics, skin care centers, others). It offers Dermatology Excimer Laser Market Trends with insights on AI integration, modular upgrades, hybrid systems, and remote connectivity. The coverage extends to Dermatology Excimer Laser Market Forecasts in unit volumes per region and per application, along with Dermatology Excimer Laser Market Insights on drivers, restraints, challenges, and opportunities. 

Dermatology Excimer Laser Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 850.66 Million in 2026
Market Size Value By	USD 1960.04 Million by 2035
Growth Rate	CAGR of 9.72% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Table Top Excimer Laser Hand Held Excimer Laser Trolley Mounted Excimer Laser By Application : Hospital Dermatology Clinic Skin Care Center Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample